StockData
MIRA Pharmaceuticals, Inc. logo

MIRA Pharmaceuticals, Inc. (MIRA) stock

MIRANasdaqPharmaceutical Preparations
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 6/30
$0.59−0.05 (-7.66%)

Close on Nov 18, 2026Market cap $24.84MP/E –Yield –

MIRA Pharmaceuticals ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

No ebitda figures for MIRA Pharmaceuticals

MIRA Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More MIRA Pharmaceuticals figures

See a number that looks wrong?